Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05015686 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

StatusUnknown
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Mar 2024); last known: Enrolling by Invitation
  2. Trial status: Active, Not Recruiting to Enrolling by Invitationv4
  3. Phase: Phase 4 to Phase 3v3 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Jul 1, 2022 to Feb 9, 2022
    • Study completion date: Dec 1, 2022 to Sep 20, 2026
    • Site details revised
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 25, 2021 to Sep 30, 2021
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This a randomized, blind, controlled clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the immunogenicity of a two doses vaccination of investigational vaccine with 0,28 day, 0,42 day and 0,56 day immunization schedule in population aged ≥13 years old.
Trial Details
NCT Number NCT05015686
Lead Sponsor Sinovac (Dalian) Vaccine Technology Co., Ltd.
Conditions
(from sponsor)		 Varicella
Related terms Chickenpox
Enrollment 2,400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov